Company Search:
Advanced Search
Sponsored Links
Xbrane Biopharma Ab Company Snapshot
Xbrane Biopharma Ab operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Xbrane Biopharma Ab with three other companies in this sector in Sweden: Rethinking Care Sweden AB (2016 sales of 1.69 million Swedish Kronor [US$205,962.55 ] ), Hansa Medical AB (2.58 million Swedish Kronor [US$315,153.80 ] of which 100% was Biomedical & Drugs), and Biovica International AB (2.43 million Swedish Kronor [US$297,132.11 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Xbrane Biopharma Ab
  Stock Performance Chart for Xbrane Biopharma Ab
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 61.60
(Figures in Swedish Kronor)
1 Week 1.3%   13 Weeks -13.6%  
4 Weeks -7.0%   52 Weeks 62.1%  
Xbrane Biopharma Ab Key Data:
  Ticker: XBRANE Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 2,490,117
(Year Ending Jan 2017).
Employees: N/A
  Currency: Swedish Kronor Market Cap: 366,937,032
  Fiscal Yr Ends: December Shares Outstanding: 5,956,770
  Share Type: Aktie Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.